Stocks›Healthcare
WatchAlert

Quality Pharmaceuticals Ltd

QUAPHAMDM · BSE · Healthcare · As of 14 Aug 2026
₹3,444.75
+₹136.35 (+4.12%)(1D)
₹828.8052 Week Range₹3,480.00
Market Cap
₹1,557 Cr
P/E (Sector)
53.1 (32.3)
P/B Ratio
—
Dividend Yield
—
ROE
1.5%
Debt / Equity
—
Anvest Score
33/100
  • Valuation
    0
  • Quality
    8
  • Growth
    47
  • Health
    100
  • Momentum
    —
Loading company profile…

Fundamentals

P/E Ratio (TTM)
53.08
Sector median P/E
32.29
P/B Ratio
—
Sector median P/B
4.4
EPS (TTM)
₹64.9
Market Cap
₹1,557 Cr
ROE
1.54%
ROCE
2.39%
Profit Margin
13.31%
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

Quality Pharmaceuticals Ltd FAQs

3 topics
Expand
What does the Quality Pharmaceuticals Ltd (QUAPHAMDM) stock page cover?
Quality Pharmaceuticals Ltd on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for QUAPHAMDM?
Quality Pharmaceuticals Ltd is currently shown with a delayed price near ₹3,444.75, P/E 53.08, and ROE 1.54%.
Does the QUAPHAMDM page provide investment advice?
No. The QUAPHAMDM page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights